PMID: 3760109Jan 1, 1986Paper

A comparison of positive family history definitions for defining risk of future disease

Journal of Chronic Diseases
S C HuntG K Barlow

Abstract

The relative risk of developing future coronary heart disease (CHD) or hypertension between positive and negative family history families is compared for different definitions of a positive family history when applied to life-table data for 94,292 persons. Having two or more first degree relatives with CHD identifies 8% of the population with relative risks of 3.3-5.9 for CHD before age 50. A quantitative family history score (FHS) compares the family's age and sex specific disease incidence to that expected in the general population and predicts future disease incidence in unaffected family members slightly better (relative risks = 3.4-6.9 for CHD before age 50). Using only one affected relative, even if affected at an early age (less than 55 years old) does not discriminate low and high risk families as well (relative risks = 1.4-3.9 for CHD before age 50). Similar results were obtained for family history of hypertension. There is an increase in future disease incidence for all ages with increasing FHS values (p less than 0.0001), which can be used as a continuous or categorical variable in analysis where family history is associated with a particular variable under study. These results provide a rational basis for choosing a...Continue Reading

References

Apr 5, 1985·JAMA : the Journal of the American Medical Association·R W SattinP M Layde
Mar 11, 1982·The New England Journal of Medicine·J W WoodsK Namboodiri

❮ Previous
Next ❯

Citations

Sep 20, 2012·JAMA : the Journal of the American Medical Association·Ted D AdamsSteven C Hunt
Sep 12, 2000·Current Hypertension Reports·Z PausovaP Hamet
Sep 30, 2010·International Journal of Behavioral Medicine·James A McCubbinD DeWayne Moore
Jan 1, 1994·Chemistry and Physics of Lipids·D E WilckenN P Dudman
Jun 19, 2004·International Journal of Cardiology·Jaw-Wen ChenWen-Harn Pan
May 23, 2001·Atherosclerosis·Y FriedlanderD S Siscovick
Feb 6, 2003·American Journal of Preventive Medicine·Paula W YoonMuin J Khoury
Feb 6, 2003·American Journal of Preventive Medicine·Sharon L R KardiaPatricia A Peyser
Feb 6, 2003·American Journal of Preventive Medicine·Anupam Tyagi, Jill Morris
Jun 2, 1998·Kidney International·H SchusterF C Luft
Apr 12, 2003·International Journal of Epidemiology·John YarnellPierre Ducimetière
Mar 20, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Maren T Scheuner
Jul 17, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Maren T Scheuner
Nov 14, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Paul N Hopkins, Steven C Hunt
Dec 19, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Maren T ScheunerEmmett Keeler
May 19, 2010·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Flavia M FacioLeslie G Biesecker
Aug 1, 1994·Australian and New Zealand Journal of Medicine·J SilberbergJ Hughes
Jun 26, 2007·Diabetes, Obesity & Metabolism·T D AdamsS C Hunt
Dec 11, 1993·BMJ : British Medical Journal·F KeeF Cambien
May 1, 1991·Gut·F KeeC C Patterson
Aug 1, 1996·Journal of Epidemiology and Community Health·H Campbell
Jul 9, 1999·Journal of Epidemiology and Community Health·M HippeT I Sørensen
Oct 12, 2000·Journal of Epidemiology and Community Health·G WattK Hunt
Jan 15, 2010·Annual Review of Public Health·Rodolfo ValdezMuin J Khoury
Jan 1, 2010·Journal of Nutrigenetics and Nutrigenomics·Steven C Hunt
Apr 28, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·M TozawaK Fukiyama
Jul 17, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Terukazu KawasakiAkira Babazono
Jan 11, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Marianne Mansour-ChemalySophie Visvikis
Dec 10, 1999·Journal of Periodontology·U M IrfanN F Bissada
May 21, 1999·Lancet·J Silberberg
Mar 1, 1997·Lancet·H H Newnham, J Silberberg
Dec 1, 1987·Controlled Clinical Trials·R R Williams, S C Hunt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.